Metastatic Urothelial Cancer

Oncology·MeSH: Urinary Bladder Neoplasms

4 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
Cabozantinib S-malate	Merus N.V. (MRUS)

Phase 2(3)

Drug	Company
BT8009	BICYCLE THERAPEUTICS PLC (BCYC)
zelenectide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
zelenectide pevedotin (formerly BT8009)	BICYCLE THERAPEUTICS PLC (BCYC)

BioSniper tracks 4 drugs in development for Metastatic Urothelial Cancer across 2 companies.

There are 1 clinical trial targeting Metastatic Urothelial Cancer tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.